找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Oral Pharmacotherapy for Male Sexual Dysfunction; A Guide to Clinical Gregory A. Broderick Book 2005 Humana Press 2005 Internist.assessmen

[復(fù)制鏈接]
樓主: Coenzyme
41#
發(fā)表于 2025-3-28 14:56:57 | 只看該作者
Physiology and Pharmacology of Erectile Dysfunction,al-generated NO, in that the latter essentially helps in maintaining penile erection. Moreover, the role of endothelium in regulating smooth muscle tone and the intercellular link by means of gap junctions have also been uncovered. More recently, research has shown that changes to the downstream sig
42#
發(fā)表于 2025-3-28 19:00:16 | 只看該作者
43#
發(fā)表于 2025-3-28 22:55:26 | 只看該作者
44#
發(fā)表于 2025-3-29 06:51:19 | 只看該作者
45#
發(fā)表于 2025-3-29 07:28:14 | 只看該作者
When to Refer the Patient With Erectile Dysfunction to a Specialist,gists. Now, as primary care physicians have become increasingly sophisticated in their knowledge of ED, they, along with their nurse practitioners and physician’s assistants, account for about two-thirds of prescriptions written for phosphodiesterase (PDE) inhibitors.
46#
發(fā)表于 2025-3-29 12:11:31 | 只看該作者
47#
發(fā)表于 2025-3-29 16:25:32 | 只看該作者
48#
發(fā)表于 2025-3-29 19:52:40 | 只看該作者
Vardenafil Clinical Trials Experience,ostheses, as first-line therapy in the majority of men seeking treatment for ED. The first of these PDE5 inhibitors was sildenafil (Viagra?). In spite of the benefits of sildenafil, its ocular effect, which manifests as dose-related changes in blue-tinted vision in some patients, reflects its weak inhibition of PDE6 and lack of selectivity.
49#
發(fā)表于 2025-3-30 03:37:54 | 只看該作者
Is Diabetic Erectile Dysfunction More Difficult to Treat?,ed by ED, compared with approx 50% in an unselected population in the Massachusetts Aging Male Survey (.,.). In another cohort of patients who had type 1 diabetes for at least 10 yr, ED was reported in 1.1% of men aged 21 to 30 yr, 55% of men aged 50 to 60 yr, and 75% of men older than 60 yr (.).
50#
發(fā)表于 2025-3-30 06:29:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 12:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
柘城县| 合作市| 五原县| 资阳市| 万州区| 安西县| 永登县| 凯里市| 江城| 石渠县| 桂阳县| 固阳县| 松潘县| 沽源县| 筠连县| 舞阳县| 安龙县| 大冶市| 博爱县| 双城市| 阳高县| 内江市| 靖西县| 深圳市| 民县| 凤城市| 盈江县| 南和县| 静宁县| 德阳市| 慈利县| 山西省| 台江县| 德昌县| 乌拉特中旗| 滕州市| 南皮县| 民乐县| 宜城市| 东乡县| 南雄市|